Boston Children's Hospital researchers identify cellular target to reduce bone marrow scarring in myelofibrosis
Source Summary
Boston Children's Hospital researchers published findings in Nature Communications identifying a new cellular target responsible for scar formation in bone marrow of myelofibrosis patients. The study suggests that combining traditional myelofibrosis therapy with drugs that block scar formation may provide more effective treatment for the blood cancer.
Why it matters
Identifying this cellular target offers a potential pathway to improve treatment outcomes for myelofibrosis patients by reducing bone marrow scarring, a key feature of the disease.
